The future potential to enable testing in different settings outside of hospital clinics is hugely exciting. Beyond Alzheimers, the technique could support research into Parkinsons disease, multiple sclerosis, ALS and brain injuries, thanks to its ability to measure NfL
Proteins 56 , 376383 (2004)
GLP-1 receptor agonist medicines such as Wegovy (semaglutide) or Mounjaro (tirzepatide) are designed to be taken once weekly
The Institute for Clinical and Economic Review deemed GLP-1s lacking in cost effectiveness for obesity management in 2022
However, repeated attacks or complications can signal a more serious problem
Pregnancy and breastfeeding Severe autoimmune diseases (without specialist supervision) Cancer during treatment no safety data for this group Children and adolescents (no clinical data) Individuals allergic to the ingredients of the preparation Quick facts No standardized protocols